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Abstract 
Background: Terpenoids are of high interest as chemical building blocks and pharmaceuticals. In microbes, terpe-
noids can be synthesized via the methylerythritol phosphate (MEP) or mevalonate (MVA) pathways. Although the MEP 
pathway has a higher theoretical yield, metabolic engineering has met with little success because the regulation of 
the pathway is poorly understood.
Results: We applied metabolic control analysis to the MEP pathway in Escherichia coli expressing a heterologous 
isoprene synthase gene (ispS). The expression of ispS led to the accumulation of isopentenyl pyrophosphate (IPP)/
dimethylallyl pyrophosphate (DMAPP) and severely impaired bacterial growth, but the coexpression of ispS and iso-
pentenyl diphosphate isomerase (idi) restored normal growth and wild-type IPP/DMAPP levels. Targeted proteomics 
and metabolomics analysis provided a quantitative description of the pathway, which was perturbed by randomizing 
the ribosome binding site in the gene encoding 1-deoxyxylulose 5-phosphate synthase (Dxs). Dxs has a flux control 
coefficient of 0.35 (i.e., a 1% increase in Dxs activity resulted in a 0.35% increase in pathway flux) in the isoprene-pro-
ducing strain and therefore exerted significant control over the flux though the MEP pathway. At higher dxs expres-
sion levels, the intracellular concentration of 2-C-methyl-d-erythritol-2,4-cyclopyrophosphate (MEcPP) increased 
substantially in contrast to the other MEP pathway intermediates, which were linearly dependent on the abundance 
of Dxs. This indicates that 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG), which consumes MEcPP, 
became saturated and therefore limited the flux towards isoprene. The higher intracellular concentrations of MEcPP 
led to the efflux of this intermediate into the growth medium.
Discussion: These findings show the importance of Dxs, Idi and IspG and metabolite export for metabolic engineer-
ing of the MEP pathway and will facilitate further approaches for the microbial production of valuable isoprenoids.
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Highlights
• Metabolic control analysis of the MEP pathway in E. 
coli.
• Dxs has high flux and concentration control over 
MEP pathway intermediates.
• Metabolomic and proteomic analysis of the MEP 
pathway.
• Reduction of MEcPP to HMBPP is a limiting step 
for flux through the MEP pathway and promotes the 
efflux of MEcPP at higher flux rates.
Background
Microbes can synthesize a broad spectrum of valuable 
compounds and precursors, providing an inexpensive 
and sustainable source of industrially-relevant chemicals 
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including terpenoids. More than 60,000 terpenoids 
have been described [1], ranging from pharmacologi-
cally active molecules such as paclitaxel and artemisinin, 
which are used for the treatment of cancer and malaria, 
respectively [2, 3], to promising biofuels such as 
farnesene [4]. All terpenoids originate from the iso-
meric precursors dimethylallyl pyrophosphate (DMAPP) 
and isopentenyl pyrophosphate (IPP), both of which are 
produced via one of two natural metabolic routes: the 
2-C-methyl-d-erythritol 4-phosphate (MEP) pathway 
and the mevalonate (MVA) pathway [5].
The MVA pathway has been engineered to produce 
large quantities of terpenoids [6, 7] but attempts to engi-
neer the MEP pathway have been less successful [8, 9]. In 
part, this reflects our incomplete knowledge of the reg-
ulation and control of the MEP pathway, despite recent 
reports that have revealed a number of regulatory mech-
anisms [10–14]. Even so, the MEP pathway is a promis-
ing target for metabolic engineering because of its higher 
theoretical yield (~ 20% more than the MVA pathway 
under aerobic conditions in Escherichia coli) and its bal-
anced use of reducing equivalents [15, 16]. Attempts to 
engineer the MEP pathway have thus far included rand-
omization approaches, the combinatorial expression of 
a subset of MEP pathway genes [17–20] and the opti-
mization of precursor supply [21]. Efforts to circumvent 
regulation by expressing the complete MEP pathway in 
heterologous hosts such as the yeast Saccharomyces cer-
evisiae have not been successful [22]. Several studies have 
investigated the rate-limiting steps in the MEP pathway, 
but have failed to deliver a consistent picture [17, 18, 20]. 
Others have found indications for the intrinsic regulation 
of the MEP pathway at the steps catalyzed by 1-deoxy-
d-xylulose-5-phosphate synthase (Dxs) and 1-deoxy-
d-xylulose-5-phosphate reductoisomerase (Dxr) [10], 
2-C-methyl-d-erythritol-4-phosphate cytidyltransferase 
(IspD) [11] or 2-C-methyl-d-erythritol-2,4-cyclopyroph-
osphate synthase (IspF) [12]. The MEP pathway interme-
diate 2-C-methyl-d-erythritol-2,4-cyclopyrophosphate 
(MEcPP) is found at higher concentrations in the extra-
cellular milieu in E. coli overexpressing MEP pathway 
genes [14]. However, the behavior of the MEP pathway 
has not been described in a precise and quantitative 
manner either in wild-type or engineered microbes.
We therefore set out to establish a quantitative descrip-
tion of the MEP pathway for terpenoid production using 
metabolic control analysis (MCA), a form of sensitivity 
analysis that quantifies the effect of small changes in a 
given parameter (such as enzyme activity) on overall sys-
tem characteristics such as metabolite concentration and 
flux [23]. Here we used the MEP pathway for the produc-
tion of isoprene. Besides having broad industrial appli-
cations, its low boiling point, and therefore its ease of 
purification, makes isoprene a promising product for fer-
mentation process [9]. The MCA framework was applied 
to the concentrations of MEP pathway metabolites and 
the flux towards isoprene according to different expres-
sion levels of the dxs gene. To our knowledge, this is the 
first time that this approach was combined with recom-
bineering, quantitative proteomics and metabolomics. 
This combination yielded a quantitative description of 
the control of Dxs on the flux through and metabolite 
concentrations in the MEP pathway, which will guide fur-
ther engineering efforts.
Materials and methods
Bacterial strains and culture conditions
Standard cloning and metabolic engineering were carried 
out using E. coli strains 10β and BL21 (DE3), respectively 
(both supplied by New England Biolabs, Ipswich, MA, 
USA). For general cloning, the bacteria were cultivated 
in lysogenic broth (LB) medium, whereas for all other 
experiments the bacteria were cultivated in M9 medium 
supplemented with 0.5% (w/v) glucose and appropri-
ate antibiotics (50  μg  mL−1 kanamycin, 100  μg  mL−1 
ampicillin and/or 25 μg mL−1 chloramphenicol) at 37 °C 
[24]. Strains carrying the plasmids pSIM5 or pSIM6 [25] 
were grown at 30 °C and cured of the plasmids at 37 °C. 
Cultures were grown in baffled Erlenmeyer flasks filled 
to one-fifth of their nominal volume and agitated at 
180  rpm. Cell growth in liquid medium was monitored 
by spectrophotometry to determine the optical density at 
600 nm  (OD600).
General cloning and amplification
General cloning procedures and plasmid purification 
were carried out according to standard laboratory prac-
tice [24]. Herculase II Fusion DNA Polymerase (Agilent 
Technologies, Santa Clara, CA, USA) was used for the 
amplification of DNA fragments by the polymerase chain 
reaction (PCR) according to the manufacturer’s instruc-
tions. All plasmids and altered genomic regions were 
verified by Sanger sequencing carried out by Eurofins 
GmbH (Ebersberg, Germany).
Construction of plasmids for the production of isoprene
The ispS gene from Populus alba was codon optimized 
for E. coli (Additional file 1: Table S1) (Thermo Fisher Sci-
entific, Waltham, MA, USA) and the gene was amplified 
using forward primer 5′-AAT AAT TTT GTT TAA CTT 
TAA TAA GGA GAT ATA CCA TGG AAG CTC GTC 
GTT CTG C-3′ and reverse primer 5′-TTA GCG TTC 
AAA TGG CAG TAG CAA GCT TGT CGA CCA CGT 
TCG AAC GGC AGG ATC-3′ (start codon in bold). Vec-
tor pCOLA was amplified using forward primer 5′-GGT 
ATA TCT CCT TAT TAA AGT TAA ACA-3′ and reverse 
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primer 5′-GGT CGA CAA GCT TGC GGC CG-3′. 
The products were joined by Gibson assembly yielding 
pCOLA::IspS, which was then amplified using forward 
primer 5′-GGC CGC ATA ATG CTT AAG TCG-3′ and 
reverse primer 5′-GCA AGC TTG TC GAC CTT AGC-
3′. The isopentenyl diphosphate isomerase (idi) gene was 
amplified from the genome of E. coli strain BL21 using 
forward primer 5′-TAC TGC CAT TTG AAC GCT AAG 
GTC GAC AAG CTT GCA AGG AGA TAT ACC ATG 
CAA ACG GAA CAC GTC AT-3′ and reverse primer 
5′-GAT TAC TTT CTG TTC GAC TTA AGC ATT ATG 
CGG CCT TAA TTG TGC TGC GCG AAA G-3′. The 
resulting fragments were again joined by Gibson assem-
bly to yield pCOLA::IspS-idi.
Construction of dxs and dxr expression libraries
Escherichia coli was transformed with pSIM5 and grown 
at 30  °C to maintain the plasmid. Accordingly, we inoc-
ulated 20  mL LB medium with 200  μL of an overnight 
grown culture of E. coli pSIM5 and incubated the culture 
until the  OD600 reached 0.5. The culture was then trans-
ferred to a water bath shaker of 42 °C and incubated for 
10 min to induce expression of gam, bet and exo. The cul-
ture was then placed in ice slurry for 10 min. After cen-
trifugation at 4000×g for 15 min at 4 °C, the supernatant 
was discarded and the pellet was resuspended in 20 mL 
double-distilled water at 0 °C and centrifuged again. This 
step was repeated twice and the pellet was then resus-
pended in 0.2 mL double-distilled water. We then added 
100 pmol of the appropriate oligonucleotide: for the dxs 
expression library the sequence was 5′-GAC TAC ATC 
ATC CAG CGT AAT AAA TAA ACA ATA ACT DDD 
RRR RRD DDD CTG ATG AGT TTT GAT ATT GCC 
AAA TAC CCG ACC CTG GCA-3′, and for the dxr 
expression library the sequence was 5′-TCG AGC CGG 
TCG AGC CCA GAA TGG TGA GTT GCT TCA TGA 
AHH HHY YYY YHH TGA GAC AGA ATA AAA AGC 
AAA ACG CCG CCA GCC GAT CCG-3′ (changes from 
the genomic sequence are underlined). The oligomers 
were designed as described by Wang et al. [8] and con-
tained four phosphorothioated bases at the 5′ terminus. 
A 50-µL aliquot of cells was used for electroporation and 
the cells were subsequently regenerated at 30 °C.
This procedure was carried out seven times with alter-
nating use of pSIM5 and pSIM6, and the appropriate 
antibiotics. After the sixth round of recombineering, the 
cells were regenerated without antibiotics at 37 °C for 2 h 
and dilutions were plated. Single colonies were used for 
colony PCR. The genomic region containing the targeted 
mutation was amplified with forward primer 5′-ACC 
AGC AAC TTG GTA AAA GTA CC-3′ and reverse 
primer 5′-CGA TTT TGT CGC GGC G-3′ for the dxs 
expression library, and with forward primer 5′-ACA 
GCC AAC GCG CTT CAA TG-3′ and reverse primer 
5′-TCG TGG TGA AGC AGA ACA AG-3′ for the dxr 
expression library. The amplicons were sequenced using 
the same primers.
Metabolite quantification
A 10-mL volume of M9 medium supplemented with 
0.5% (w/v) glucose was inoculated with 100  µL of over-
night culture in 200-mL Erlenmeyer flasks. A 1-mL ali-
quot was withdrawn from the culture at  OD600 ≈ 0.5 and 
centrifuged at 13,000×g for 1 min at 4 °C. The superna-
tant was discarded and the pellet was resuspended in 
90 µL quenching solution at − 20 °C, before adding 10 µL 
360  µM azidothymidine [26]. The quenching solution 
contained 40% methanol, 40% acetonitrile and 20% dou-
ble-distilled water acidified with 0.5% formic acid [27]. 
The sample was incubated at − 20 °C for 1 h for quantita-
tive extraction of MEP pathway intermediates. The solu-
tion was centrifuged at 17,000×g for 1  min at 4  °C and 
transferred to a measuring vial.
For the analysis of extracellular metabolites, 1  mL of 
culture was withdrawn and immediately centrifuged at 
13,000×g for 1 min at 4 °C. A 20-µL aliquot of the super-
natant was mixed with 70 µL of modified quenching solu-
tion (50% methanol, 50% acetonitrile acidified with 0.25% 
formic acid) and 10 µL 360 µM azidothymidine [26].
Calibration curves for absolute quantification were 
generated using analytical standards for all target metab-
olites. The standards were stored lyophilized at − 20  °C 
before preparing dilution series of mixed analytical 
standards in quenching solution. Calibration curves 
of intracellular metabolites were prepared by mixing 
90  µL of each set of diluted standards with a lyophi-
lized extract of 1  mL E.  coli culture grown in minimal 
medium with U-13C glucose to  OD600 = 0.5, to account 
for the matrix effects of other metabolites in E. coli. This 
step was skipped for the calibration curve of extracellu-
lar metabolites. We added 10 µL of the internal standard 
360 µM azidothymidine. The solution was centrifuged at 
17,000×g for 1 min at 4 °C and transferred to a measur-
ing vial. To calculate the intracellular concentration from 
the concentration in the sample, an intracellular volume 
factor of 3.6 µL mL−1 OD−1600 was assumed [28].
The metabolites were analyzed using a Shimadzu 
(Tokyo, Japan) HPLC system coupled to a 6500 QTRAP 
mass spectrometer (Sciex, Darmstadt, Germany). The 
autosampler was cooled to 15 °C. The flow was held con-
stant at 0.25  mL  min−1. The oven was heated to 40  °C. 
The metabolites were separated according to the reversed 
phase ion pairing principle on a Nucleoshell RP18 col-
umn (2.7 µm, 90 Å, 100 mm) (Macherey–Nagel, Düren, 
Germany). Two buffers were used: Buffer A comprised 
15  mM tributylamine and 20  mM formic acid, whereas 
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buffer B was 100% methanol. The elution started with 0% 
buffer B for 2 min, followed by an increase to 40% buffer 
B over 1 min, a hold at 40% buffer B for 3 min, an increase 
to 100% buffer B over 6 min, then a decrease to 0% buffer 
B over 1 min, and a final hold for 4 min. Baseline separa-
tion of all intermediates other than IPP and DMAPP was 
achieved (Additional file 1: Fig. S1). The mass spectrom-
eter was operated in negative mode with unit resolution 
for the mass filter Q1 and Q3 with optimized parameters 
for the HPLC method (Additional file  1: Table  S2). The 
optimized parameters for each metabolite are listed in 
Additional file 1: Table S3.
Protein quantification
We inoculated 50-mL of medium with 0.5 mL overnight 
culture and induced gene expression with 1 mM isopro-
pyl β-d-1-thiogalactopyranoside (IPTG) at  OD600 = 0.1. 
The culture was incubated until the  OD600 reached 0.5 
and then prepared as described by Gaida et al. [29].
In silico prediction of peptide mass and fragment size
In silico predictions and single reaction monitoring 
(SRM) screens were carried out using Skyline software 
[30]. After in silico digestion with trypsin, we excluded 
peptides outside the size range 8–20 amino acids, those 
containing cysteine residues or those with potential 
ragged ends due to tandem arginine and/or lysine resi-
dues. The remaining peptides were screened for double-
charged species with single-charged y-series fragments 
after collision in collision cell Q2. Peptides and fragments 
with m/z values outside the range 50–1000  Da were 
excluded. The declustering potential and collision energy 
for all fragments were optimized in Skyline. Predicted 
transitions were sought in lysates of the E. coli BL21 
strains overexpressing the corresponding gene. Proteo-
typic peptides were selected for each protein according to 
several criteria: (i) at least two transitions with high sig-
nal-to-noise ratios; (ii) retention times for all transitions 
equal and close to the predicted value [30]; (iii) transi-
tions unique in the E. coli proteome, ensured by search-
ing the NCBI database using BLAST [31] and Mascot 
[32]; and (iv) transition signal strength is orders of mag-
nitude lower in the negative control not overexpressing 
the corresponding gene. If all criteria matched, proteo-
typic peptides were selected with the highest signal-to-
noise ratio to achieve maximum sensitivity.
Synthetic internal standard and calibration curve
After selecting one proteotypic peptide for each protein 
of interest, precise quantities of each peptide were syn-
thesized (JPT, Berlin, Germany) in normal and heavy 
forms, the latter containing 13C and 15N labeled lysine 
and arginine (SpikeTides L, JPT). The m/z values for 
detection of the labeled peptides were modified accord-
ingly. All synthetic peptides included a C-terminal Qtag 
modification (JPT) that can be cleaved with trypsin. We 
used 1  nmol of heavy labeled peptides as an internal 
standard and this was introduced to the sample before 
reduction with dithiothreitol. The early introduction of 
the internal standard as well as the tag, which has to be 
cleaved off, ensures quantitative quality control through-
out sample preparation and sample analysis. Known 
quantities of the synthetic peptides were used to establish 
a calibration curve based on the same preparation proto-
col used for all the other samples, including the addition 
of an internal standard. Again, an intracellular volume of 
3.6 µL mL−1 OD−1600 was assumed [28].
Separation and detection of peptides
The peptides were separated by LC–MS/MS [33]. A 
5-µL sample was injected into the Ascentis Express Pep-
tide ES-C18 column (5  cm × 2.1  mm, 2.7  µm) (Sigma-
Aldrich, St Louis, MO, USA) equipped with a compatible 
guard column. The peptides were eluted at a flow rate 
of 400 µL min−1 in 2% acetonitrile plus 98% double-dis-
tilled water containing 0.1% formic acid (buffer A) and 
98% acetonitrile plus 2% double-distilled water contain-
ing 5% formic acid (buffer B). Elution began at 5% buffer 
B increasing to 40% buffer B in 17 min and then to 95% 
buffer B in 0.5 min, followed by a hold for 1 min before 
decreasing to 5% buffer B in 0.5 min and a hold for 3 min 
for re-equilibration. The peptides were quantified using 
Multiquant (Sciex, Darmstadt, Germany) according to 
the details provided in Additional file 1: Table S4. Base-
line separation was achieved for all measured peptides 
(Additional file 1: Fig. S2).
Isoprene quantification
Escherichia coli cultures were grown in M9 medium con-
taining 0.1% (w/v) glucose in baffled Erlenmeyer flasks. 
At  OD600 = 0.1, the cultures were induced with 1  mM 
IPTG. At  OD600 = 0.5, several 1-mL aliquots of the cul-
ture were transferred to 10-mL vials and crimp-sealed. 
The sealed aliquots remained growing at 37  °C while 
shaking. At specific time points, vials were moved to boil-
ing water and incubated for 5 min before cooling to 4 °C.
External calibration curves were used for quantification 
with a dilution series of commercial isoprene. All sam-
ples were incubated at 37  °C for at least 10  min before 
quantification. A heated syringe was used to withdraw 
200 µL from the gas phase and to inject the sample into 
the heated (100  °C) injection port of the TQ8030 GC–
MS/MS (Shimadzu). The samples were separated on a 
ZB-XLB-HT-Inferno capillary column (30 m × 0.25 mm, 
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0.25  µm) (Phenomenex, Aschaffenburg, Germany) with 
helium as the carrier gas. The temperature program 
began at 40  °C for 1 min, increasing linearly to 80  °C in 
1 min followed by a hold for 1 min. Isoprene was detected 
in multiple reaction monitoring (MRM) mode with the 
transitions from 68.1 to 67 m/z and from 67.1 to 41 m/z 
with collision energies of 13 and 10 kV, respectively. The 
ion source was kept at 200 °C and the interface at 250 °C.
Chemicals and reagents
Unless stated otherwise, all chemicals and inducers were 
purchased from Sigma-Aldrich. The following standards 
for the quantification of MEP pathway intermediates 
were supplied by Echelon Biosciences (Salt Lake City, 
UT, USA): 2-C-methyl-d-erythritol 4-phosphate (MEP), 
1-deoxy-d-xylulose 5-phosphate (DXP), isopentenyl 
pyrophosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP). HPLC–MS-grade solvents were supplied 
by Carl-Roth (Karlsruhe, Germany) and U-13C-glucose 
was purchased from Cambridge Isotope Laboratories 
(Tewksbury, MA, USA). Gases for GC were purchased 
from Linde AG (Munich, Germany).
Determination of flux by label incorporation
Fluxes in the MEP pathway in wild-type and mutants 
were calculated from the absolute 13C incorporation into 
DXP in time course labeling assays ranging from 10 s to 
30 min. Overnight cultures of E. coli were used for inocu-
lating of 40  mL of M9 minimal medium with appropri-
ate antibiotics to an  OD600 of ~ 0.02 AU. A temperature 
controlled vessel (custom-built, Ochs, Jena) was used 
for cultivation. The glucose concentration was adjusted 
to 0.05% with a 20% (w/v) glucose solution. This glucose 
concentration was calculated to be sufficient to allow 
the culture to grow to  OD600 of 0.5 with residual glu-
cose concentration high enough to prevent carbon star-
vation. The cultures were grown at 37  °C while stirred 
with a magnet to an  OD600 of ~ 0.1 AU and induced with 
1 mM IPTG. U-13C-glucose was added to a final concen-
tration of 0.05% at an  OD600 of ~ 0.5 AU. At chosen time 
points, 1 mL of culture was withdrawn and injected into 
a 10 mL 2% NaCl solution, kept at 0 °C to slow down fur-
ther metabolism. The quenched culture was then imme-
diately filtered through a 0.45-µm-filter (0.45 µm, 22 mm, 
PVDF, Merck Milipore) in a Swinnex filter holder (Merck 
Milipore). The filter was then transferred for extraction 
to a vessel with 1  mL 80% methanol [26], precooled to 
0  °C. After an incubation time of 10 min, the extraction 
solution was transferred to a 2-mL-tube and the filter 
was extracted again and washed with 1  mL methanol. 
The extracts were merged and centrifuged at 15,000g 
for 1  min at 4  °C. The supernatant was transferred to a 
new tube and evaporated at 60 °C to dryness. The pellet 
was dissolved in 50 µL ddH2O and the metabolites were 
measured via LC–MS/MS. The calculation for non-
stationary 13C-flux analysis, was adapted from Wright 
et  al. [34]. The total labeled fraction of DXP was calcu-
lated using the m0 through m5 molecular ion species 
obtained from LC–MS/MS analysis according to the 
equation 1/N
∑
N
i=1Mi × i [35], were N is the number 
of carbon atoms in the molecule and Mi is the fractional 
abundance of the ith isotopologue. The isotopologues are 
represented by mn with n being the number of 13C atoms 
incorporated. Natural abundances of 13C, 17O, and 18O 
were measured in unlabeled standards and subtracted 
from labeled sample mass spectra to determine exact 
13C amounts introduced during labeling. After plotting 
total fraction labeled against corrected labeling time, data 
were fitted to curves as the exponential rise to maximum, 
according to the equation A×
(
1− e[−k×t]
)
 , where A is 
the labeling plateau, t is the labeling time, and k is the 
kinetic rate constant. Equations were fitted to the time 
course data for each plant line by iteratively adjusting A 
and k to minimize χ2 values using the Levenberg–Mar-
quardt minimization algorithm as implemented in the 
SciPy library of scientific computational routines (http://
www.scipy .org). Seed estimates were obtained by visual 
inspection of the labeling maxima of the curves (for A), 
and by using 1/t1/2 (for k). The flux was then calculated 
for each line by multiplying the DXP pool size by the fit-
ted rate constant k.
Results and discussion
Introducing isoprene synthase into E. coli
We chose to synthesize isoprene, an important plat-
form chemical, as a model terpenoid in E. coli as it 
has several advantages over other terpenoids. Its syn-
thesis in microbes requires only the expression of one 
heterologous gene, ispS. Furthermore, its high volatil-
ity reduces toxicity, facilitates product recovery and 
reduces feedback inhibition by the product [9]. We 
employed the ispS gene from Populus alba, because it 
has been used in many microbial engineering processes 
and is known to express well [7, 9, 20]. We analyzed 
the E. coli strain overexpressing the ispS gene under 
the control of the T7 promoter through quantitative 
proteomics and metabolomics. The induction of ispS 
expression strongly inhibited bacterial growth (Fig. 1a). 
Metabolomic characterization revealed a strong 
increase in the concentration of IPP/DMAPP and also 
higher concentrations of MEcPP (Fig. 1b). Because IspS 
produces isoprene from DMAPP via the elimination of 
diphosphate (Fig.  1c), we speculated that the catalytic 
activity of Idi (converting IPP to DMAPP) was too low 
to keep up with the consumption of DMAPP by IspS, 
which would result in low concentrations of DMAPP. 
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Most enzymes that consume IPP also need DMAPP 
as a substrate, so the production of native terpenoids 
would be inhibited and the excess IPP would remain 
unconsumed. A feedback inhibition of Dxs by IPP and 
DMAPP by DMAPP/IPP as in Populus trichocarpa [13] 
would enhance this effect. The proposed low specific 
activity of Idi was further supported by proteomic anal-
ysis of the MEP pathway in E. coli. Here all of the MEP 
pathway enzymes except of Idi were detected, meaning 
that less than 10 copies of Idi per cell are present, given 
the limit of detection (Fig. 2). This is consistent with the 
idi gene being non-essential as confirmed by the nor-
mal growth of the idi mutant, in contrast to the other 
MEP pathway genes [36]. Tests involving the randomi-
zation of the idi ribosome binding site (RBS) to change 
the expression level had no effect on the abundance of 
the enzyme or the amount of isoprene produced (data 
not shown). We hypothesise that it is likely that the 
ratio of IPP to DMAPP synthesized by (E)-4-hydroxy-
3-methylbut-2-enyl diphosphate reductase (IspH), 
which is 5:1 in E.  coli [37], evolved to match the ratio 
needed for terpenoid synthesis and therefore idi is not 
expressed or expressed at low levels under normal con-
ditions. Consequently, modulation of the translation 
rate of idi through mutation of the RBS has little effect 
on the expression. Expression of idi might be induced 
under conditions, where there is an increased demand 
for specific terpenoid products.
The specific activity of Idi was increased by over-
expression of a plasmid-borne idi gene under the 
control of the T7 promoter, provided by the vector 
pCOLA::IspS-idi. The coexpression of idi and ispS over-
came the growth impairment observed with ispS alone, 
and restored the native levels of IPP/DMAPP (Fig. 1b). 
For all further experiments, idi was coexpressed with 
ispS in order to prevent the isomerase from limiting the 
flux or inhibiting bacterial growth.
Proteomic and metabolomic analysis of the MEP pathway
The maximum reaction rate per cell (Vmax), the reaction 
rate under substrate saturation, of the enzymes in  vivo 
was calculated by multiplying the protein abundance 
(Fig.  2) with its turn over number  (kcat) from literature. 
The values lay between 4.8 × 103 (IspG) and 1.8 × 107 
(Dxr) molecules  cell−1  min−1 as shown in Table  1. The 
turnover numbers of IspG and IspH were measured using 
artificial reducing agents [49, 50] and it is unclear how 
these conditions relate to those in vivo.
The enzymatic steps catalyzed by Dxs and Dxr lie 
behind the branching points of the MEP pathway: glyc-
eraldehyde phosphate (GAP) and pyruvate are glycolytic 
intermediates, DXP is the substrate for the synthesis of 
pyridoxal [38] and thiamine phosphate [39]. Therefore, 
the concentrations of these intermediates depend not 
only on the MEP pathway, but also on enzymes outside 
of the MEP pathway and will therefore probably not 
Fig. 1 Expression of isoprene synthase (ispS) in E. coli. Strains carrying the empty plasmid pCOLA, the plasmid containing ispS (pCOLA::IspS) 
or the plasmid containing ispS and idi (pCOLA::IspS-idi) are compared. a Influence on E. coli growth. E. coli carrying the empty plasmid shows 
normal exponential growth kinetics. b Influence on MEP pathway intermediate concentrations. The concentration is shown relative to wild-type 
bacteria carrying the empty vector pCOLA. The data represent the mean of biological triplicates ( x± SE; n = 3). c The MEP pathway in E. coli. 
The metabolite DXP is also a precursor for the synthesis of vitamin  B6 and thiamin. Ispoprene can be synthesized through the heterologous 
expression of ispS (shown in red). DXP 1-deoxy-d-xylulose 5-phosphate, MEP 2-C-methyl-d-erythritol 4-phosphate, MEcPP 2-C-methyl-d-erythritol 
2,4-cyclopyrophosphate, ME-CDP 4-diphosphocytidyl-2-C-methylerythritol, MEP-CDP 4-diphosphocytidyl-2-C-methyl-d-erythritol 2-phosphate, 
HMBPP 4-hydroxy-3-methyl-but-2-enyl pyrophosphate, IPP isopentenyl pyrophosphate, DMAPP dimethylallyl pyrophosphate, GAP glyceraldehyde 
3-phosphate, Dxs DXP synthase, Dxr DXP reductoisomerase, IspD MEP cytidylyltransferase, IspE ME-CDP kinase, IspF MEcPP synthase, IspG HMBPP 
synthase, IspH HMBPP reductase, Idi isopentenyl diphosphate isomerase, IspS isoprene synthase
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result in substrate saturation of these enzymes. In con-
trast, the remaining MEP pathway intermediate pools 
(MEP, ME-CDP, MEP-CDP, MEcPP and HMBPP) only 
depend on the activities of the MEP pathway enzymes 
responsible for their synthesis and subsequent conver-
sion. Therefore, these concentrations can be correlated 
to the flux through the MEP pathway, and substrate satu-
ration of the consuming enzyme is then possible. Hence, 
these enzymes could in principle reach Vmax. The reac-
tion rate (v) of Dxs and Dxr can be calculated based on 
the substrate concentrations. The concentration of any 
cofactors is ignored in this consideration. The intracellu-
lar concentration in E. coli of GAP is 10.3 µM [40], which 
is 4.6% of the Michaelis constant (Km) of Dxs (226  µM 
according to Brammer and Meyers [41]) resulting in 
a v of 3.7 × 102  molecules  cell−1  min−1. The reaction 
rate of Dxr lies between 4.9 × 102 and 8.4 × 105  mole-
cules cell−1 min−1 depending on which literature values 
are used for the calculation (Additional file 1: Table S5) 
[42–44]. Therefore, the reaction rate of Dxs is predicted 
to be the lowest among the MEP pathway enzymes, apart 
from Idi (Table  1). Therefore, Dxs potentially exerts a 
high flux control on the MEP pathway [45]. Furthermore, 
it occupies a key position in the pathway [45]. Hence, 
Dxs was chosen for further analysis. The intracellular 
concentration of GAP is much lower than the Km of Dxs, 
which explains why manipulating the GAP concentration 
strongly influences the flux through the MEP pathway 
[21, 46].
The major intermediate pools of the MEP pathway are 
DXP and MEcPP (Fig. 2b). For all enzymes, the measured 
substrate concentrations lay far below their  Km values 
(Table  2). As a consequence, the flux is highly adapt-
able to substrate availability, as the flux can be strongly 
increased when substrate accumulates or reduced when 
substrate concentration falls [52]. In contrast, the activ-
ity of enzymes, which are not on branching points, exerts 
little control on the flux, allowing the pathway to be reg-
ulated by its first enzyme, Dxs. Furthermore, this sub-
maximal flux gives the pathway a reserve flux capacity, 
which is the difference between the flux with the given 
substrate concentration  (Km ≫ substrate concentration) 
Fig. 2 a Concentration of MEP pathway enzymes in E. coli. Idi was not detected. b Concentration of MEP pathway intermediates in E. coli. MEP-CDP 
was not quantified because it is highly unstable, and HMBPP was not detected. ( x± SD; n = 3)
Table 1 Catalytic power of the MEP pathway enzymes in E. coli 
a  Kinetics were partly determined using artificial reducing agents
b  Calculated from a Vmax of 162.9 nmol min
−1 for 5 µg pure IspE and using 31 kDa as the molecular weight of IspE
Enzyme kcat  (10
3  min−1) References for kcat Amount per cell Maximum reaction rate 
per cell (Vmax)  (10
3 molecules 
 min−1 cell−1)
Dxs 0.25 [41] 64 ± 4 16
Dxr 1.3; 6.7; 5.9 × 102 [42–44] 32 ± 5 41; 2.1 × 102; 1.8 × 104
IspD 2.94 [47] 50 ± 8 1.48 × 102
IspE 1.01b [48] 208 ± 22 2.1 × 102
IspF 0.06 111 ± 13 6.66
IspG 0.024a [49] 204 ± 25 4.83
IspH 1.13a [50] 218 ± 22 2.46 × 102
Idi 0.0048–0.02 [36, 51] < 10 < 0.2
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and the maximum flux under substrate saturation 
 (Km ≪ substrate concentration). This reserve flux capac-
ity allows for a quick increase in flux without the need of 
changes in gene expression [53].
Construction and evaluation of a dxs expression library
A dxs expression library was constructed to investigate 
the control exerted by Dxs on the flux through the MEP 
pathway. In order to minimize alterations to the genome 
and hence to the overall metabolism, recombineering 
was used to mutate the RBS of dxs. The benefit of this 
approach is that no polarity effects need to be consid-
ered and the plasmid carrying the genetic tools can be 
removed by curing before further experiments, leaving a 
near-wild-type genome containing only the desired muta-
tion. After seven cycles of recombineering, the region 
containing the dxs RBS was sequenced, revealing that 
~ 40% of the clones contained the desired randomization 
(Additional file 1: Table S6). Proteomic analysis revealed 
changes in the Dxs content of the mutant strains, rang-
ing from 25 to 357% (Fig.  3a). Nine mutants and the 
wild-type were transformed with pCOLA::IspS-idi. 
Importantly, the concentration of all other MEP pathway 
enzymes showed no significant changes (Fig.  3b). This 
allowed the analysis of Dxs isolated from other compo-
nents of the MEP pathway. Likewise, a dxr expression 
library was constructed (Additional file 1: Table S7), but 
despite the heterogeneous expression levels (Additional 
file 1: Fig. S3), the mutations did not lead to changes in 
isoprene production (data not shown) and no further 
evaluations were carried out.
Isoprene emission in the dxs expression library
The impact of changes in Dxs concentration on isoprene 
production in the strain expressing the isoprene synthase 
was evaluated under aerobic growth conditions. Because 
isoprene is highly volatile (boiling point = 36  °C), assays 
were conducted in sealed flasks with sufficient oxygen 
to allow aerobic growth until measurement. In order to 
assess the productivity over time, the start and end pro-
duction levels were measured precisely by sealing the 
culture at the specific time point and inactivating the 
culture by a sudden increase in temperature. Isoprene 
production per unit time and biomass was constant over 
the duration of the experiment (Additional file 1: Fig. S4), 
indicating that the in vivo conditions remained constant 
during incubation. In the strain expressing a plasmid 
encoded isoprene synthase and idi gene, isoprene pro-
duction as a function of dxs expression was well fitted 
by the function 0.8 × 0.35 (Fig. 4). The control coefficient 
was 0.35 at wild-type dxs expression levels (Additional 
file 1: Fig. S5). At higher dxs expression levels, isoprene 
production saturated and Dxs therefore exerted less con-
trol over isoprene productivity. This is in accordance with 
the theory that flux control in the pathway is shared, and 
is shifted towards other enzymes if the activity of one 
enzyme increases [56]. The saturation effect was already 
Table 2 Concentration of  MEP intermediates compared 
to the Km values of the downstream enzymes
a  [41]; b [40]; c [42]; d [43]; e [44]; f [48]; g [47]; h [54]; i [49]; j [55]; k [36]
Enzyme Km (µM) Concentration 
in E. coli (µM)
Dxs 226  GAPa 10.3b
Dxr 99c;  115d;  720e DXP 16.8 ± 0.7
IspD 61f;  370g MEP 0.75 ± 0.04
IspE 150h ME-CDP 0.92 ± 0.02
IspG 311i; 560–700j MEcPP 12.2 ± 0.01
Idi ~ 9.5/14.3k IPP/DMAPP 1.3 ± 0.2
Fig. 3 Expression differences in the dxs expression library. a Dxs content relative to wild-type. Data are means of biological triplicates ( x± SD, n = 3). 
b Concentration of MEP pathway enzymes. Clones 1–10 were analyzed ( x± SD, n = 30)
Page 9 of 15Volke et al. Microb Cell Fact          (2019) 18:192 
pronounced when Dxs concentration had increased by 
less than twofold, suggesting that further increase in dxs 
expression levels are likely to have only a minor addi-
tional impact on isoprene production. This is in agree-
ment with the observation that severe overexpression 
of dxs under the control of the T7 promoter increases 
isoprene production by about threefold in batch fermen-
tation (Additional file 1: Fig. S6). The effect of dxs over-
expression on terpenoid production was similar to the 
range reported in other studies [8, 17, 18].
Metabolic characterization of the MEP pathway in the dxs 
expression library
The concentrations of the MEP pathway intermediates 
were determined in the dxs expression library express-
ing ispS and idi from pCOLA::IspS-idi. The intermedi-
ate MEP-CDP was not quantified due to its instability. 
The isomers IPP and DMAPP were quantified together. 
HMBPP was present at levels below the limit of detection 
in all samples (0.39  µM). Remarkably, the expression of 
ispS and idi led to a significant increase in the levels of all 
measured metabolites except MEcPP (Additional file  1: 
Table S8). We speculate that this effect might be due to a 
feedback inhibition by a metabolite further downstream 
in the terpenoid biosynthesis pathway, whose concentra-
tion is reduced through the diversion of the carbon flux 
into isoprene.
The concentration of all intermediates was linearly 
dependent on the concentration of Dxs at wild-type 
expression levels and below (Fig.  5a, b), whereas higher 
concentrations of Dxs caused a massive increase in the 
levels of MEcPP (Fig. 5b), while the levels of IPP/DMAPP 
approached saturation (Fig.  5a). These characteristics 
indicate that as IspG reached substrate saturation and 
approached its  Vmax, the effect of higher substrate con-
centrations on the reaction rate decreased. Furthermore, 
we suspected that not all the flux entering the MEP path-
way was reaching IPP/DMAPP, which results in a less-
than-expected increase in IPP/DMAPP concentrations. 
This diverted flux was later confirmed to be metabolite 
export. The levels of DXP, MEP and ME-CDP were lin-
early dependent on dxs expression, whereas levels of IPP/
DMAPP were best fitted by the power law with the equa-
tion  4.3 × 0.35. Notably, the IPP/DMAPP concentration 
had the same exponent as isoprene production, which 
leads to a linear dependency of these values (Additional 
file  1: Fig. S7). The metabolite concentration control 
coefficient of Dxs decreased with increasing distance 
in the pathway to the metabolite pool (Additional file 1: 
Table S9).
Flux through DXP
The direct quantification of all products of the MEP path-
way is difficult, as a large variety of different terpenoids 
is produced, of which some are conjugated to other mol-
ecules, for example in the prenylation of proteins. There-
fore, non-stationary 13C flux analysis was used to assess 
the flux through the MEP pathway. Here, the informa-
tion about time-dependent label incorporation into the 
metabolite pools of DXP was used to quantify the carbon 
flux through the pathway (Additional file 1: Fig. S9).
The flux through the MEP pathway increased with 
increased expression levels of dxs in E. coli expressing 
ispS and idi from the plasmid pCOLA::IspS-idi (Fig. 6a). 
The flux control coefficient of Dxs on the flux through 
DXP (0.65) is very high (Fig.  6b), meaning that the flux 
changes 0.65% with every 1% change in Dxs activity. The 
summation theorem of MCA states that the flux control 
coefficients of all enzymes in a metabolic pathway sum 
to one [23]. This suggests that Dxs is the major flux-
controlling enzyme of the MEP pathway. Furthermore, a 
higher flux through DXP was observed upon expression 
of IspS and Idi compared to the wild type carrying the 
empty plasmid (Fig. 6a). This increase could be either due 
to an activation of the pathway by IspS, or because Idi: 
IspS consumes DMAPP, which is known to inhibit Dxs, 
the first enzymatic reaction of the MEP pathway [13]. 
Idi could increase the flux through balancing the pool 
of DMAPP and IPP and thereby accelerate downstream 
reactions.
Even though the control of Dxs on the isoprene pro-
duction saturated (Fig. 4), the flux did not. This indicates 
that the flux was directed into other sinks at higher dxs 
expression (e.g. terpenoids and exported metabolites). 
This also agrees with the observation that the flux con-
trol coefficient on the early pathway metabolite, DXP, 
Fig. 4 Isoprene production in engineered E. coli strains with altered 
dxs expression levels. The dotted line represents a fit of the data to 
the power function 0.8 × 0.35 While the fit was performed on all data 
points individually, the data are visualized as x± SD (n = 3) for clarity
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is higher than on isoprene, as part of the flux does not 
reach isoprene. The observed flux through DXP was 
several times higher than the sum of DXP and MEcPP 
export and isoprene emission, which could be due to the 
production of endogenous terpenoids.
Export of MEP pathway intermediates
To determine whether part of the flux leaves the MEP 
pathway before reaching IPP/DMAPP, we analyzed 
the culture supernatants. MEP, DXP and MEcPP were 
detected in the spent medium of cultures producing 
Fig. 5 Concentration of MEP, IPP/DMAPP, and ME-CDP (a), and MEcPP and DXP (b) in response to changes in dxs expression ( x± SD, n = 3). The 
graphs for MEP, ME-CDP and DXP are fitted with a linear fit through zero, while IPP/DMAPP is fitted with a power law  (R2 > 0.95). The intermediate 
concentrations were measured in the dxs RBS library expressing ispS and idi from pCOLA::IspS-idi. The cultures were induced at  OD600 = 0.1 and 
the intermediates were quantified at  OD600 ≈ 0.5. The concentration of MEcPP in response to dxs expression was fitted to two piecewise linear 
segments. The graph is divided at the wild-type expression level, with overexpression yielding a slope more than 14-fold steeper than under 
expression. The metabolite concentration control coefficient of Dxs over MEcPP for the overexpression of dxs is 2.6. Other concentration-control 
coefficients are given in Additional file 1: Table S9 and were calculated according to Additional file 1: Fig. S8, the double logarithmic plot of the data 
in this figure
Fig. 6 a Dependence of carbon flux through the DXP pathway on dxs expression in E. coli wild type carrying the empty plasmid pCOLA (•) and in 
the strain expressing ispS and idi from the plasmid pCOLA::IspS-idi (•). The data was fitted by linear regression. b Logarithmic plot of the flux through 
DXP as a function of dxs expression. The data was fitted with a second-degree polynomial function
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isoprene (Fig.  7a). The export rates of DXP and MEcPP 
into the supernatant increased as dxs expression levels 
increased (Fig.  7b). MEP was detected in the superna-
tant, but concentrations were too low for kinetic meas-
urements. The export rate of DXP increased linearly with 
increasing dxs expression, while the increase in MEcPP 
efflux rate into the supernatant was more than linear 
(Fig. 7b, c). The MEcPP efflux rate was, however, propor-
tional to the intracellular MEcPP concentration (Fig. 7d). 
This supports the hypothesis that MEcPP is exported 
rather than reduced to HMBPP as a consequence of the 
flux into the MEP pathway being higher than the Vmax of 
IspG. The total flux towards extracellular DXP, MEcPP 
and isoprene increased drastically with increased expres-
sion of dxs (Fig. 7e).
Conclusions
The metabolic engineering of the MEP pathway in 
microbes has significant potential for the industrial pro-
duction of terpenoids, but this approach has not been 
as successful as anticipated mainly because the regula-
tion of the MEP pathway is not fully understood. Here, 
we investigated the behavior of the MEP pathway in 
metabolically engineered E. coli, producing the model 
Fig. 7 Specific efflux rates of MEP pathway intermediates calculated from their measured concentrations in the supernatant of cultures of the 
E. coli Bl21 dxs RBS library expressing ispS and idi from pCOLA::IspS-idi ( x  ± SD, n = 3). The cultures were induced at  OD600 = 0.1 and the supernatant 
was sampled at  OD600 ≈ 0.5. The export of MEP pathway intermediates occurred after the induction of ispS expression in the dxs expression 
library. a Metabolite concentration in the supernatant of the cultures. b DXP and MEcPP efflux rates as a function of dxs expression relative to 
wild-type levels. Linear fits through zero and second-degree polynomial fits through zero are shown for DXP and MEcPP, respectively in (a) and 
(b). c Logarithmic plot of MEcPP efflux rate as a function of dxs expression. The data were fitted to a linear function with a slope of 2.0. The red 
marked data point was excluded from the fit. d The correlation of MEcPP efflux rate with its intracellular concentration, linear fitted through zero. e 
Combined efflux of DXP, MEcPP and isoprene in dependents of dxs expression, linear fitted
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Fig. 8 Metabolic characterization of the MEP pathway in E. coli expressing isoprene synthase and isopentenyl pyrophosphate isomerase from 
a plasmid. The intracellular metabolite concentrations, secretion rate of metabolites and isoprene production rate are plotted against dxs 
expression. The expression strength of dxs was modulated by randomization of its ribosome-binding site. DXP 1-deoxy-d-xylulose 5-phosphate, 
MEP 2-C-methyl-d-erythritol 4-phosphate, MEcPP 2-C-methyl-d-erythritol 2,4-cyclopyrophosphate, ME-CDP 4-diphosphocytidyl-2-C-methyleryth
ritol, MEP-CDP 4-diphosphocytidyl-2-C-methyl-d-erythritol 2-phosphate, HMBPP 4-hydroxy-3-methyl-but-2-enyl pyrophosphate, IPP isopentenyl 
pyrophosphate, DMAPP dimethylallyl pyrophosphate, GAP glyceraldehyde 3-phosphate, Dxs DXP synthase, Dxr DXP reductoisomerase, IspD MEP 
cytidylyltransferase, IspE ME-CDP kinase, IspF MEcPP synthase, IspG HMBPP synthase, IspH HMBPP reductase, Idi isopentenyl diphosphate isomerase, 
IspS isoprene synthase
terpenoid isoprene. Firstly, we have confirmed that the 
overexpression of idi increases the growth rate of the 
isoprene production strains and increases the isoprene 
production rate, making it a crucial target for terpe-
noid production. Secondly, we have shown that the 
substrate concentration of all MEP pathway enzymes 
is well below their  Km, which gives the pathway a high 
sensitivity of its flux towards substrate changes. Fur-
thermore, we provided a detailed picture of the control 
of Dxs (Fig. 8) in a production strain, expressing a plas-
mid-based isoprene synthase and idi. Dxs has substan-
tial control over the flux through the metabolite pool of 
DXP over the entire analyzed expression range (Fig. 6). 
In contrast, the control over the production of isoprene 
is high at wild-type dxs expression levels and below, 
but this influence decreases rapidly when the enzyme 
is overexpressed. The metabolite concentrations of the 
MEP pathway intermediates gave further insight into 
this behavior: The concentrations of DXP, MEP and 
ME-CDP, the first metabolites of the MEP pathway, 
were linearly dependent on dxs expression over the 
investigated range (Fig. 5) and therefore the concentra-
tion control coefficients of Dxs for these metabolites 
are 1. Likewise, the concentration of MEcPP showed 
a linear dependence on Dxs levels below the wild type 
expression level, but a steep increase at higher expres-
sion levels with a concentration control coefficient 
of 2.6 (Fig.  5b). In contrast, the concentration of IPP/
DMAPP and the flux towards isoprene showed a sat-
urating behavior, both with a control coefficient of 
0.35 (Figs. 4 and 5a) at wild-type dxs levels. The steep 
increase in MEcPP concentration and the decrease in 
the concentration control coefficient between MEcPP 
and IPP/DMAPP implies a flux limiting conversion 
step in the pathway between these metabolites. Nei-
ther the catalytic steps between MEP, DXP, ME-CDP 
and MEcPP, nor between IPP/DMAPP and isoprene 
seem to limit the flux. The increase in the concentra-
tion of DXP and MEcPP correlated with an increase 
efflux thereof (Fig. 7), which caused the majority of the 
flux of the MEP pathway to leak into the extracellular 
space rather than being channeled into isoprene. There-
fore, the activity of the enzymes converting MEcPP 
into IPP/DMAPP (i.e., IspG and IspH) may well have 
to be increased to reach higher fluxes in MEP pathway 
towards terpenoids in cell factories. However, simple 
overexpression of IspG and IspH did not increase the 
flux towards terpenoids in this work nor did it in other 
works [17]. IspG needs several cofactors for its activity 
[57, 58], and this may affect the ability of the enzyme to 
function as expected when overexpressed.
Therefore, besides identifying Idi and Dxs as major 
flux controlling steps and vital metabolic engineering 
targets for microbial terpenoid production, we show 
that further research is required to determine the pre-
cise mechanism of IspG and potentially IspH to allow 
higher activity thereof to the end of full exploitation 
of the MEP pathway for the efficient production of 
terpenoids.
To our knowledge, this is the first use of recombineer-
ing combined with targeted proteomics and metabo-
lomics for the precise metabolic control analysis of a 
specific pathway.
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